The Emerging Role of Herbal Medicines in Cancer by Interfering with Posttranslational Modifications
Antioxidants & Redox Signaling · 01.01.2025 · 42 (1-3) · 150-164
DOI: 10.1089/ars.2023.0418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, erschienen am 01.01.2025. Verfasst von Rui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China. Hauptthemen laut MEDLINE: Neoplasms, Protein Processing, Post-Translational, Herbal Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 102 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, China.
- Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, International Institute for Translational Chinese Medicine, Guangzhou University of…
ORCID-Profile: Linlin Lu
Zitieren
APA
Wang, R., Li, Y., Ji, J., Kong, L., Huang, Y., Liu, Z., & Lu, L. (2025). The Emerging Role of Herbal Medicines in Cancer by Interfering with Posttranslational Modifications. Antioxidants & Redox Signaling, 42(1-3), 150-164. https://doi.org/10.1089/ars.2023.0418
Vancouver
Wang R, Li Y, Ji J, Kong L, Huang Y, Liu Z, et al. The Emerging Role of Herbal Medicines in Cancer by Interfering with Posttranslational Modifications. Antioxidants & Redox Signaling. 2025;42(1-3):150-164. doi:10.1089/ars.2023.0418
BibTeX
@article{Wang2025,
author = {Wang, Rui and Li, Yu and Ji, Jiahui and Kong, Lingwei and Huang, Yukai and Liu, Zhongqiu and Lu, Linlin},
title = {The Emerging Role of Herbal Medicines in Cancer by Interfering with Posttranslational Modifications},
journal = {Antioxidants & Redox Signaling},
year = {2025},
volume = {42},
number = {1-3},
pages = {150--164},
doi = {10.1089/ars.2023.0418}
}
EUVIMED